Important TB drug as effective at lower dose, study finds

The treatment of drug-resistant forms of tuberculosis has been transformed over the last decade with treatment becoming more effective, safer, and treatment duration in many cases dropping to under a year. Even so, treatment can still come with serious side effects and for some, it can still last over a year and a half. In a finding that may help further reduce side effects, new research has found that the dosage of a key drug can be lowered without compromising how well it works. Tiyese Jeranji and Marcus Low report.

Read More

Opinion: Could community health workers be the answer to reducing Tuberculosis stigma?

Tuberculosis stigma thrives when TB is spoken about in hushed whispers, or behind closed doors. The truth is anyone who breathes can get TB as it is an airborne disease like COVID-19. We can all reduce the harmful effect of TB stigma in our communities by taking part in activities that break down false and unfair attitudes towards people with TB. Community health workers are leading the way and deserve more support, write authors from TB Proof.

Read More

How safe is your data on the EVDS?

With the 1 July opening of registration for those aged 50-59, over 4.8 million more people can now register on South Africa’s Electronic Vaccination Data System (EVDS). They will join a few million people before them in providing personal information including their names, ID numbers, cell phone numbers, and medical aid numbers if applicable. Laura Owings asks how safe your data is on the EVDS.

Read More